REMIT: Escitalopram linked to lower rate of mental stress-induced myocardial ischemia

  • May 21, 2013

Results from the randomized, double blind, placebo-controlled REMIT trial suggest that 6 weeks of treatment with the antidepressant escitalopram — a selective serotonin reuptake inhibitor — was associated with a significant reduction in the rate of mental stress-induced myocardial ischemia among patients with stable CHD.

“Recent evidence suggests that selective serotonin reuptake inhibitors (SSRIs) may reduce mental stress-induced hemodynamic response, metabolic risk factors, and platelet reactivity,” researchers wrote in a study published in JAMA.

Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More »
More »
  • Healio Minute, May 21, 2013
  • Healio Minute logo
  • First drink, new rule, best advice
  • Timing of first drink really matters, CMS floats trial “observation” balloon and healthy providers give best hypertension advice.
More »
More »
[X]